For more information, please visit noom.com, subscribe to our blog, or follow us on Twitter and LinkedIn
September 2023: The FDA notes reports of Ileus, a gastrointestinal disorder, following use of Ozempic
In clinical studies, individuals using Wegovy reported losing between 14.9% and 17.4% of their body weight over a 68-week period
On the right, exendin-4 is shown bound to the GLP-1 receptor (PDB 7LLL)
Self-Administration and Accessibility Medications like semaglutide and tirzepatide need to be self-administered, which means youll need to be capable of injecting yourself
Those allergic to specific peptide components should avoid products containing those ingredients